1. Home
  2. PRLD vs SDHY Comparison

PRLD vs SDHY Comparison

Compare PRLD & SDHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated

HOLD

Current Price

$5.58

Market Cap

391.1M

Sector

Health Care

ML Signal

HOLD

Logo PGIM Short Duration High Yield Opportunities Fund

SDHY

PGIM Short Duration High Yield Opportunities Fund

HOLD

Current Price

$16.07

Market Cap

404.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRLD
SDHY
Founded
2016
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
391.1M
404.4M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
PRLD
SDHY
Price
$5.58
$16.07
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$5.67
N/A
AVG Volume (30 Days)
368.5K
44.7K
Earning Date
05-13-2026
01-01-0001
Dividend Yield
N/A
8.46%
EPS Growth
23.21
N/A
EPS
N/A
1.07
Revenue
$12,140,000.00
N/A
Revenue This Year
$320.10
N/A
Revenue Next Year
$100.00
N/A
P/E Ratio
N/A
$15.17
Revenue Growth
73.43
N/A
52 Week Low
$0.83
$15.55
52 Week High
$5.91
$17.18

Technical Indicators

Market Signals
Indicator
PRLD
SDHY
Relative Strength Index (RSI) 62.16 45.97
Support Level $3.92 $15.86
Resistance Level $5.62 $16.23
Average True Range (ATR) 0.46 0.19
MACD 0.11 0.01
Stochastic Oscillator 71.51 29.82

Price Performance

Historical Comparison
PRLD
SDHY

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.

About SDHY PGIM Short Duration High Yield Opportunities Fund

PGIM Short Duration High Yield Opportunities is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation. It mainly invests in a diversified portfolio of high-yield fixed-income instruments that are rated below investment grade with varying maturities and other investments (including derivatives) with similar economic characteristics.

Share on Social Networks: